Medicines and Healthcare products Regulatory Agency
Following the success of its first public meeting on 12 February 2016, the Board, under the chairmanship of Sir Michael Rawlins, has decided to open part of its next meeting in April to the public.
The Agency will also hold public board meetings on 12 September and 12 December.
The public session will be held in the morning before a private session in the afternoon. By necessity, discussion of policy matters in development, commercial or staff confidentiality, certain emerging regulatory issues, forthcoming announcements or publications will be taken in private session.
Details
151 Buckingham Palace Road
London
SW1W 9SZ
There is space for 15 members of the public to attend the public session of the open board meeting. Registration will be on a first come, first served basis. We will inform you by email on 9 April to confirm arrangements.
See the draft agenda For information about the session and register your interest via email to directorate@mhra.gsi.gov.uk if you are a general member of the public. Media representatives should contact the News Centre on 020 3080 7651 or email newscentre@mhra.gsi.gov.uk.
Members of the public will have an opportunity to ask questions at the end of each discussion item at the discretion of the Chair.